Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

UCSD Cardiologist Receives NIH New Innovator Award

 

October 08, 2010  |  

The National Institutes of Health has chosen Neil Chi, MD, PhD, assistant professor of medicine in the division of cardiology at the University of California, San Diego, as one of its 2010 NIH Director’s New Innovator Award recipients.

With this $2.3 million award, Chi and his team will study the remarkable ability of the zebrafish to regenerate the heart.  The team has created a collection of tools which will help in understanding the underlying mechanisms of cardiac regeneration.  “Heart failure is the leading cause of death in the United States,” said Dr. Chi.  “We hope to someday apply what we learn from the zebrafish heart regeneration process towards understanding how to directly reprogram human cells into ventricular cardiomyocytes for the regeneration of injured hearts from patients afflicted with heart attacks and/or heart failure.”

Chi is one of 52 New Innovator honorees nationwide, including 13 researchers from within the University of California.  "NIH is pleased to be supporting early-stage investigators from across the country who are taking considered risks in a wide range of areas in order to accelerate research," said Francis S. Collins, MD, PhD, director of the National Institutes of Health. "We look forward to the results of their work."

Established in 2007, the NIH Director's New Innovator Award funds new investigators who propose highly innovative research projects that could have an exceptionally great impact on biomedical or behavioral science.  The award program is designed to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu




Media Contact

Share This Article


Related News

5/26/2020
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
5/21/2020
During COVID-19, UC San Diego Health expanded telehealth to provide patients with safe and convenient access to appointments with their health care providers. Video visits expanded by more than 50-fol ...
5/19/2020
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and ne ...
5/15/2020
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites ...



Follow Us